VYNE Therapeutics Inc. VYNE 27.7
Health Care · NASDAQ · Data as of 2026-06-03
VYNE Therapeutics Inc. (VYNE) has delivered -19.6% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1933 of 1993 stocks overall and #249 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
27.7
Overall Rank
#1933 / 1993
Sector Rank
#249 / 264
Revenue CAGR
-19.6%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio